Orion Semi (Digoxin)

Digoxin, the active ingredient in Orion Semi, is a cardiac glycoside presented as a strength/form for oral use. It is used to manage certain heart rhythm disorders and heart failure in adult patients. GNH USA supplies Orion Semi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Orion Semi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Orion Semi contains digoxin, a cardiac glycoside that acts on the cardiovascular system to improve cardiac efficiency.

- Atrial fibrillation: helps control ventricular rate by increasing vagal tone. - Heart failure: modestly improves symptoms and exercise tolerance by increasing contractile force. - Supraventricular tachycardia: assists in rate control when other agents are unsuitable.

Digoxin may cause a range of adverse reactions, most of which are dose‑related and require monitoring.

Common Side Effects: - Nausea and vomiting: mild gastrointestinal upset. - Visual disturbances: blurred or yellow‑green vision. - Fatigue: general tiredness or weakness. - Headache: mild to moderate head pain.

Serious or Rare Side Effects: - Cardiac arrhythmias: potentially life‑threatening rhythm disturbances. - Hyperkalemia: elevated potassium levels, especially in renal impairment. - Severe bradycardia: markedly slow heart rate. - Allergic reactions: rash, itching, or anaphylaxis.

When prescribing Orion Semi, clinicians should consider several safety measures.

- Renal function: adjust dose in patients with impaired clearance. - Electrolyte balance: monitor potassium and magnesium levels. - Drug interactions: review concomitant medications for additive effects. - Thyroid disease: use caution in hyperthyroid patients. - Pregnancy and lactation: evaluate risk‑benefit ratio carefully. - Store at ambient temperature: keep in original container, protect from moisture and light.

Digoxin interacts with several medicines that can alter its plasma concentration or cardiac effects.

Major Interactions (Avoid): - Amiodarone: increases digoxin levels, raising toxicity risk. - Quinidine: reduces renal clearance, elevating serum concentrations. - Verapamil: potentiates digoxin’s negative chronotropic effect.

Moderate Interactions (Monitor Closely): - Diuretics (loop, thiazide): may cause electrolyte shifts that predispose to arrhythmias. - ACE inhibitors: can lower potassium, enhancing toxicity potential. - Beta‑blockers: additive bradycardic effect. - Antacids containing aluminum or magnesium: may decrease absorption.